- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 564-578 of
645 results
1623 Exhibit: Exhibit 1623a ¿¿¿An Exploratory Study to Improve Sales Operations W...
Document
IPR2017-00190, No. 1623 Exhibit - Exhibit 1623a ¿¿¿An Exploratory Study to Improve Sales Operations When Selling Multiple Prescription Drugs,¿¿¿ JC Yi, M Zhou, T Park, Journal of Supply Chai...
|
|
Cite Document
2117 Exhibit: Kaken Exhibit 2117
Document
IPR2017-00190, No. 2117 Exhibit - Kaken Exhibit 2117 (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
1522 Exhibit: Exhibit 1522a Theodore Rosen et al, Seminars in Cutaneous Medicin...
Document
IPR2017-00190, No. 1522 Exhibit - Exhibit 1522a Theodore Rosen et al, Seminars in Cutaneous Medicine and Surgery Onychomycosis Diagnosis, Treatment, and Prevention Strategies Supp 3...
|
|
Cite Document
1514 Exhibit: Pharmacokinetics of antimycotics with emphasis on local treatment
Document
IPR2017-00190, No. 1514 Exhibit - Pharmacokinetics of antimycotics with emphasis on local treatment (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1543 Exhibit: Exhibit 1543a ¿¿¿Is Walgreens Valeant¿¿¿s New Philidor¿¿¿ D A Hussar, ...
Document
IPR2017-00190, No. 1543 Exhibit - Exhibit 1543a ¿¿¿Is Walgreens Valeant¿¿¿s New Philidor¿¿¿ D A Hussar, The Pharmacist Activist, vol 11, no 2 February 2016 (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
1515 Exhibit: Label for Kerydin¿¿ tavaborole topical solution, 5%, Anacor Pharmace...
Document
IPR2017-00190, No. 1515 Exhibit - Label for Kerydin¿¿ tavaborole topical solution, 5%, Anacor Pharmaceuticals, Inc (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1669 Exhibit: Declaration of Caitlin M Wilmot in Support of Petitioners¿¿¿ Response t...
Document
IPR2017-00190, No. 1669 Exhibit - Declaration of Caitlin M Wilmot in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 (P.T.A.B. Jan. 5, ...
|
|
Cite Document
1508 Exhibit: Deposition Transcript of Dr Boni E Elewski
Document
IPR2017-00190, No. 1508 Exhibit - Deposition Transcript of Dr Boni E Elewski (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1553 Exhibit: Exhibit 1553a Valeant Pharmaceuticals International, Inc, US Securit...
Document
IPR2017-00190, No. 1553 Exhibit - Exhibit 1553a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2015...
|
|
Cite Document
1502 Exhibit: Trends in the management of cutaneous fungal infections
Document
IPR2017-00190, No. 1502 Exhibit - Trends in the management of cutaneous fungal infections (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
3003 Exhibit: Ex 3003
Document
IPR2017-00190, No. 3003 Exhibit - Ex 3003 (P.T.A.B. Aug. 4, 2020)
|
|
Cite Document
3002 Exhibit: Exhibit 3002
Document
IPR2017-00190, No. 3002 Exhibit - Exhibit 3002 (P.T.A.B. Jun. 22, 2020)
|
|
Cite Document
1018 Exhibit: EX1018 Franz
Document
IPR2017-01429, No. 1018 Exhibit - EX1018 Franz (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1023 Exhibit: EX1023 Mertin and Lippold III
Document
IPR2017-01429, No. 1023 Exhibit - EX1023 Mertin and Lippold III (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1001 Exhibit: EX1001 US Pat No 7,214,506
Document
IPR2017-01429, No. 1001 Exhibit - EX1001 US Pat No 7,214,506 (P.T.A.B. May. 12, 2017)
|
|
Cite Document
